Centerspace (CSR) stock
CSRNYSEReal Estate Investment TrustsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 16/3056% below fair value
$56.94+0.70 (+1.24%)
Close on Nov 13, 2026Market cap $956.26MP/E 10.7Yield 5.41%
Centerspace EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Centerspace's EPS for the twelve months ending Sep 30, 2026 was $5.34, up 198.3% year over year. For fiscal 2025 it was $1.02. The highest annual figure on record is $8.71 in fiscal 2018.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.02 | – |
| FY2024 | Dec 31, 2024 | -$1.27 | -154.7% |
| FY2023 | Dec 31, 2023 | $2.32 | – |
| FY2022 | Dec 31, 2022 | -$1.35 | – |
| FY2021 | Dec 31, 2021 | -$0.47 | – |
| FY2020 | Dec 31, 2020 | -$0.15 | -101.7% |
| FY2018 | Apr 30, 2018 | $8.71 | +237.6% |
| FY2017 | Apr 30, 2017 | $2.58 | -47.5% |
| FY2016 | Apr 30, 2016 | $4.91 | +346.4% |
| FY2015 | Apr 30, 2015 | $1.10 | – |
| FY2014 | Apr 30, 2014 | -$2.30 | -235.3% |
| FY2013 | Apr 30, 2013 | $1.70 | +142.9% |
| FY2012 | Apr 30, 2012 | $0.70 | -68.2% |
| FY2011 | Apr 30, 2011 | $2.20 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | $7.28 | +128.2% |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$0.07 | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$0.77 | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$1.10 | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $3.19 | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$0.87 | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$0.22 | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$0.31 | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -$0.40 | -197.6% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$0.19 | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$0.37 | -113.4% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$0.59 | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $0.41 | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$0.23 | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $2.76 | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -$0.24 | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -$0.14 | -109.5% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$0.30 | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -$0.68 | – |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | -$0.79 | -157.2% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $1.48 | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -$0.49 | – |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | -$0.46 | – |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $1.38 | -87.7% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -$0.44 | -183.0% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | -$0.69 | – |
| Q4 FY2018CQ1 2018 | Apr 30, 2018 | -$1.89 | -181.1% |
| Q3 FY2018CQ4 2017 | Jan 31, 2018 | $11.22 | +610.1% |
| Q2 FY2018CQ3 2017 | Oct 31, 2017 | $0.53 | -26.4% |
| Q1 FY2018CQ2 2017 | Jul 31, 2017 | -$1.12 | – |
| Q4 FY2017CQ1 2017 | Apr 30, 2017 | $2.33 | +232.9% |
| Q3 FY2017CQ4 2016 | Jan 31, 2017 | $1.58 | -47.3% |
| Q2 FY2017CQ3 2016 | Oct 31, 2016 | $0.72 | -34.5% |
| Q1 FY2017CQ2 2016 | Jul 31, 2016 | -$2.02 | -2120.0% |
| Q4 FY2016CQ1 2016 | Apr 30, 2016 | $0.70 | 0.0% |
| Q3 FY2016CQ4 2015 | Jan 31, 2016 | $3.00 | – |
| Q2 FY2016CQ3 2015 | Oct 31, 2015 | $1.10 | – |
| Q1 FY2016CQ2 2015 | Jul 31, 2015 | $0.10 | – |
| Q4 FY2015CQ1 2015 | Apr 30, 2015 | $0.70 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?